Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil-based regimen-refractory advanced or recurrent gastric cancer in Korea and Japan: Preliminary results

被引：8
|
作者：
Kim, Y. H.
Sasaki, Y.
Lee, K. H.
Rha, S. Y.
Park, S.
Boku, N.
Komatsu, Y.
Kim, T.
Kim, S.
Sakata, Y.
机构：
[1] Korea Univ, Coll Med, Seoul 136705, South Korea
[2] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[3] Yeungnam Univ Hosp, Taegu, South Korea
[4] Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Yonsei Canc Ctr, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[6] Shizuoka Canc Ctr, Shizuoka, Japan
[7] Hokkaido Univ Hosp, Dept Canc Ctr, Sapporo, Hokkaido, Japan
[8] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[9] Kyung Hee Univ Hosp, Seoul, South Korea
[10] Misawa Municipal Hosp, Misawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.87
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
87
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer: Preliminary results
    Cordio, S.
    Rosati, G.
    Camaghi, C.
    Mattina, M.
    Lavenia, G.
    Sambataro, D.
    Latteri, F.
    Salice, P.
    Sergi, C.
    Amadio, P.
    Parra, H. Soto
    ANNALS OF ONCOLOGY, 2005, 16 : 49 - 49
  • [2] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [3] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 570 - 576
  • [4] Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen - Two parallel randomized phase II studies
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Fontana, T
    Noviello, MR
    Landriscina, M
    Colloca, G
    Astone, A
    CANCER, 1998, 82 (08) : 1460 - 1467
  • [5] Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
    Satoh, Taroh
    Lee, Kyung Hee
    Rha, Sun Young
    Sasaki, Yasutsuna
    Park, Se Hoon
    Komatsu, Yoshito
    Yasui, Hirofumi
    Kim, Tae-You
    Yamaguchi, Kensei
    Fuse, Nozomu
    Yamada, Yasuhide
    Ura, Takashi
    Kim, Si-Young
    Munakata, Masaki
    Saitoh, Soh
    Nishio, Kazuto
    Morita, Satoshi
    Yamamoto, Eriko
    Zhang, Qingwei
    Kim, Jung-mi
    Kim, Yeul Hong
    Sakata, Yuh
    GASTRIC CANCER, 2015, 18 (04) : 824 - 832
  • [6] Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
    Taroh Satoh
    Kyung Hee Lee
    Sun Young Rha
    Yasutsuna Sasaki
    Se Hoon Park
    Yoshito Komatsu
    Hirofumi Yasui
    Tae-You Kim
    Kensei Yamaguchi
    Nozomu Fuse
    Yasuhide Yamada
    Takashi Ura
    Si-Young Kim
    Masaki Munakata
    Soh Saitoh
    Kazuto Nishio
    Satoshi Morita
    Eriko Yamamoto
    Qingwei Zhang
    Jung-mi Kim
    Yeul Hong Kim
    Yuh Sakata
    Gastric Cancer, 2015, 18 : 824 - 832
  • [7] A RANDOMIZED PHASE II STUDY OF BIWEEKLY IRINOTECAN VERSUS IRINOTECAN PLUS 5-FLUOROURACIL/LEUCOVORIN AS A SALVAGE CHEMOTHERAPY IN PREVIOUSLY TREATED PATIENTS WITH ADVANCED GASTRIC CANCER
    Sym, S.
    Park, Y.
    Park, S.
    Park, J.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
  • [8] Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen
    Park, SH
    Kang, WK
    Lee, HR
    Park, J
    Lee, KE
    Lee, SH
    Park, JO
    Kim, K
    Kim, WS
    Chung, CW
    Im, YH
    Lee, MH
    Park, CH
    Park, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (05): : 477 - 480
  • [9] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan (Folfiri) in patients with previously untreated advanced gastric cancer
    Cordio, S.
    Rosati, G.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Bordonaro, R.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 22 - 22
  • [10] Results of the phase II portion of a phase I/II study of pemetrexed plus irinotecan in patients with advanced colorectal cancer previously treated with a 5-fluorouracil (5-FU)-containing regimen
    Kettner, Erika
    Kroening, Hendrik
    Hochster, Howard
    Becker, Klaus
    Peschel, Christian
    Ramanathan, Ramesh K.
    Macdonald, Jack
    Hong, Shengyan
    John, Bill
    Schmoll, Hans-Joachim
    ANNALS OF ONCOLOGY, 2004, 15 : 85 - 86
12345